The results of this study show that the increase in the expression of piR-651 and piR-823 during gonad development and in cancer may be associated with hormone levels in some cancer cells, and that these piRNA expressions vary depending on the hormone level and cancer cell type in the microenvironment of the cancer. The gene discussed is PIR; the disease is cancer.